A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital …
SK Kjaer, K Sigurdsson, OE Iversen… - Cancer prevention …, 2009 - AACR
Quadrivalent human papillomavirus (HPV) vaccine has been shown to provide protection
from HPV 6/11/16/18–related cervical, vaginal, and vulvar disease through 3 years. We …
from HPV 6/11/16/18–related cervical, vaginal, and vulvar disease through 3 years. We …
A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital …
SK Kjaer, K Sigurdsson, OE Iversen… - Cancer Prevention …, 2009 - europepmc.org
Quadrivalent human papillomavirus (HPV) vaccine has been shown to provide protection
from HPV 6/11/16/18-related cervical, vaginal, and vulvar disease through 3 years. We …
from HPV 6/11/16/18-related cervical, vaginal, and vulvar disease through 3 years. We …
A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital …
SK Kjaer, K Sigurdsson, OE Iversen… - Cancer prevention …, 2009 - pubmed.ncbi.nlm.nih.gov
Quadrivalent human papillomavirus (HPV) vaccine has been shown to provide protection
from HPV 6/11/16/18-related cervical, vaginal, and vulvar disease through 3 years. We …
from HPV 6/11/16/18-related cervical, vaginal, and vulvar disease through 3 years. We …
A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External …
SK Kjaer, K Sigurdsson, OE Iversen… - Cancer Prevention …, 2009 - portal.research.lu.se
Quadrivalent human papillomavirus (HPV) vaccine has been shown to provide protection
from HPV 6/11/16/18-related cervical, vaginal, and vulvar disease through 3 years. We …
from HPV 6/11/16/18-related cervical, vaginal, and vulvar disease through 3 years. We …
A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital …
SK Kjaer, P Garcia, KA Ault, SM Garland… - CANCER …, 2009 - researchportal.tuni.fi
A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types
6/11/16/18) vaccine against high-grade cervical and external genital lesions — Tampere …
6/11/16/18) vaccine against high-grade cervical and external genital lesions — Tampere …
A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital …
SK Kjaer, K Sigurdsson, OE Iversen… - Cancer prevention …, 2009 - researchportal.helsinki.fi
A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types
6/11/16/18) vaccine against high-grade cervical and external genital lesions — University of …
6/11/16/18) vaccine against high-grade cervical and external genital lesions — University of …
A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (types 6/11/16/18) vaccine against high-grade cervical and external genital …
SK Kjaer, K Sigurdsson, OE Iversen… - 2009 - lareferencia.info
Quadrivalent human papillomavirus (HPV) vaccine has been shown to provide protection
from HPV 6/11/16/18-related cervical, vaginal, and vulvar disease through 3 years. We …
from HPV 6/11/16/18-related cervical, vaginal, and vulvar disease through 3 years. We …
A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External …
SK Kjaer, K Sigurdsson, OE Iversen… - Cancer Prevention …, 2009 - lup.lub.lu.se
Quadrivalent human papillomavirus (HPV) vaccine has been shown to provide protection
from HPV 6/11/16/18-related cervical, vaginal, and vulvar disease through 3 years. We …
from HPV 6/11/16/18-related cervical, vaginal, and vulvar disease through 3 years. We …
A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (types 6/11/16/18) vaccine against high-grade cervical and external genital …
SK Kjaer, K Sigurdsson, OE Iversen… - 2009 - repository.urosario.edu.co
Quadrivalent human papillomavirus (HPV) vaccine has been shown to provide protection
from HPV 6/11/16/18-related cervical, vaginal, and vulvar disease through 3 years. We …
from HPV 6/11/16/18-related cervical, vaginal, and vulvar disease through 3 years. We …
A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital …
SK Kjaer, K Sigurdsson, OE Iversen… - Cancer prevention …, 2009 - research.regionh.dk
Quadrivalent human papillomavirus (HPV) vaccine has been shown to provide protection
from HPV 6/11/16/18-related cervical, vaginal, and vulvar disease through 3 years. We …
from HPV 6/11/16/18-related cervical, vaginal, and vulvar disease through 3 years. We …